Kurm Pharma ApS: Financial statements 2022
CVR: 39181274
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Kurm Pharma ApS (CVR 39181274) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 459,138 and a net result of DKK 332,526 compared with DKK 1,996,154 the year before. That is a decrease of 82.4% compared with the year before. Equity in the 2022 report amounted to DKK 3,247,761. The solvency ratio was 87.9%.
- Gross Profit
- DKK 459,138
- Profit/Loss
- DKK 332,526
- Equity
- DKK 3,247,761
- Total Assets
- DKK 3,696,916
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 459 t. | 333 t. | 3.2 mio. | - |
| 2021 | - | 2.6 mio. | 2 mio. | 3.1 mio. | - |
| 2020 | - | 947 t. | 705 t. | 969 t. | - |
| 2019 | - | 667 t. | 506 t. | 904 t. | - |
| 2018 | - | 494 t. | 348 t. | 398 t. | - |
Official annual report
Keep an eye on Kurm Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Kurm Pharma ApS has published its annual report for 2021. Gross profit came to DKK 2,610,379, and the net result was DKK 1,996,154.
About Kurm Pharma ApS
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033.